cas 4956-05-2|| where to buy 6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

製品名:6-Bromo-1,2,4-triazine-3,5(2H,4H)-dione

IUPAC Name:6-bromo-2,3,4,5-tetrahydro-1,2,4-triazine-3,5-dione

包装単位	有効在庫	価格（USD）
CM253184-25g	in stock	ĳǎ
CM253184-100g	in stock	ţǭĳ

研究開発用専用.

問い合わせフォーム

化学物質名

CAS番号

数量*

要求仕様*
（アッセイ %、材料グレード等）

お名前*

連絡先Eメールアドレス*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 4956-05-2 regularly via the above email.

追記事項

Verification code*

refresh

: CAS番号:4956-05-2; 分子式:C3H2BrN3O2; 融点:-; SMILESコード:O=C(N1)NN=C(Br)C1=O; 密度:

: カタログ番号:CM253184; 分子量:191.97; 沸点:; MDL番号:MFCD00154757; 保管方法:Keep in inert atmosphere, store at 2-8°C.

: Triazines; Triazines are an important class of six-membered aromatic heterocycles with three nitrogen atoms that give rise to three regioisomers: 1,2,4-triazines, 1,2,3-triazines, and 1,3, 5-triazine. 1,2,3-Triazines show remarkable reactivity and have attracted attention for their medicinal value. Triazine compounds fused with other carbon and heterocycles are stable and have a broad spectrum of pharmacological activities.

: ALG-055009; Aligos Therapeutics announced positive topline results from the Phase 2a HERALD study of ALG-055009, a thyroid hormone receptor beta (THR-β) agonist, in metabolic-dysfunction associated steatohepatitis (MASH) subjects. ALG-055009 demonstrated a favorable tolerability profile with no serious adverse events (SAEs), or clinical hyper/hypothyroidism. The majority of treatment emergent adverse events (TEAEs) were mild to moderate, with one discontinuation due to worsening insomnia in a subject with pre-existing insomnia.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.